Cargando…
Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212214/ https://www.ncbi.nlm.nih.gov/pubmed/32399097 http://dx.doi.org/10.5114/aoms.2020.94504 |
| _version_ | 1783531577517539328 |
|---|---|
| author | Nabavi, Seyed Fazel Habtemariam, Solomon Clementi, Emilio Berindan-Neagoe, Ioana Cismaru, Cosmin Andrei Rasekhian, Mahsa Banach, Maciej Izadi, Morteza Bagheri, Mahdi Bagheri, Mohammad Sadegh Nabavi, Seyed Mohammad |
| author_facet | Nabavi, Seyed Fazel Habtemariam, Solomon Clementi, Emilio Berindan-Neagoe, Ioana Cismaru, Cosmin Andrei Rasekhian, Mahsa Banach, Maciej Izadi, Morteza Bagheri, Mahdi Bagheri, Mohammad Sadegh Nabavi, Seyed Mohammad |
| author_sort | Nabavi, Seyed Fazel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7212214 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Termedia Publishing House |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72122142020-05-12 Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 Nabavi, Seyed Fazel Habtemariam, Solomon Clementi, Emilio Berindan-Neagoe, Ioana Cismaru, Cosmin Andrei Rasekhian, Mahsa Banach, Maciej Izadi, Morteza Bagheri, Mahdi Bagheri, Mohammad Sadegh Nabavi, Seyed Mohammad Arch Med Sci Research Paper Termedia Publishing House 2020-04-14 /pmc/articles/PMC7212214/ /pubmed/32399097 http://dx.doi.org/10.5114/aoms.2020.94504 Text en Copyright: © 2020 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
| spellingShingle | Research Paper Nabavi, Seyed Fazel Habtemariam, Solomon Clementi, Emilio Berindan-Neagoe, Ioana Cismaru, Cosmin Andrei Rasekhian, Mahsa Banach, Maciej Izadi, Morteza Bagheri, Mahdi Bagheri, Mohammad Sadegh Nabavi, Seyed Mohammad Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 |
| title | Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 |
| title_full | Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 |
| title_fullStr | Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 |
| title_full_unstemmed | Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 |
| title_short | Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 |
| title_sort | lessons learned from sars-cov and mers-cov: fda-approved abelson tyrosine-protein kinase 2 inhibitors may help us combat sars-cov-2 |
| topic | Research Paper |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212214/ https://www.ncbi.nlm.nih.gov/pubmed/32399097 http://dx.doi.org/10.5114/aoms.2020.94504 |
| work_keys_str_mv | AT nabaviseyedfazel lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT habtemariamsolomon lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT clementiemilio lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT berindanneagoeioana lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT cismarucosminandrei lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT rasekhianmahsa lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT banachmaciej lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT izadimorteza lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT bagherimahdi lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT bagherimohammadsadegh lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 AT nabaviseyedmohammad lessonslearnedfromsarscovandmerscovfdaapprovedabelsontyrosineproteinkinase2inhibitorsmayhelpuscombatsarscov2 |